Pages that link to "Q35616042"
Jump to navigation
Jump to search
The following pages link to Humoral immune response and immunoglobulin G Fc receptor genotype are associated with better clinical outcome following idiotype vaccination in follicular lymphoma patients regardless of their response to induction chemotherapy (Q35616042):
Displaying 22 items.
- Efficacious immune therapy in chronic myelogenous leukemia (CML) recognizes antigens that are expressed on CML progenitor cells (Q33526746) (← links)
- Blocking NK cell inhibitory self-recognition promotes antibody-dependent cellular cytotoxicity in a model of anti-lymphoma therapy (Q33607045) (← links)
- Immunoglobulin G Fc receptor FcgammaRIIIa 158 V/F polymorphism correlates with rituximab-induced neutropenia after autologous transplantation in patients with non-Hodgkin's lymphoma (Q33627797) (← links)
- Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR). (Q33672480) (← links)
- Immunoglobulin G Fc receptor polymorphisms do not correlate with response to chemotherapy or clinical course in patients with follicular lymphoma (Q34021592) (← links)
- Idiotype vaccines for lymphoma: Potential factors predicting the induction of immune responses (Q35113388) (← links)
- NK cell-based immunotherapies in Pediatric Oncology. (Q35600975) (← links)
- Anti-idiotype antibodies in cancer treatment (Q36832098) (← links)
- BiovaxID idiotype vaccination: active immunotherapy for follicular lymphoma (Q36837124) (← links)
- Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment (Q37152107) (← links)
- Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular lymphoma (Q37237431) (← links)
- Generation of CD8 T cell-mediated immunity against idiotype-negative lymphoma escapees (Q37420514) (← links)
- Idiotype vaccines for lymphoma: proof-of-principles and clinical trial failures (Q37585099) (← links)
- Current and Potential Uses of Immunocytokines as Cancer Immunotherapy (Q37637949) (← links)
- Modulation of tumor immunity by therapeutic monoclonal antibodies (Q37832438) (← links)
- Idiotype vaccines for lymphoma therapy. (Q37892587) (← links)
- Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapy. (Q39214969) (← links)
- Phage idiotype vaccination: first phase I/II clinical trial in patients with multiple myeloma. (Q42215347) (← links)
- BiovaxID®: a customized idiotype vaccine for the treatment of B-cell lymphoma. (Q43905270) (← links)
- Concomitant combination of active immunotherapy and carboplatin- or paclitaxel-based chemotherapy improves anti-tumor response (Q45367630) (← links)
- Construction, expression and in vitro biological effects of idiotype Ig Fab fragment of B-chronic lymphocytic leukemia. (Q54415635) (← links)
- [Natural killer cells and cancer. Regulation by the killer cell Ig-like receptors (KIR)] (Q84282458) (← links)